Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease.
Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease.
复制标题
计算机断层扫描的心脏形态测量和慢性阻塞性肺疾病β-受体阻滞剂治疗减轻病情加重。
DOI:
10.1164/rccm.201702-0399le
复制
发表时间:
2017
影响因子:
24.7
通讯作者:
Washko,G
中科院分区:
文献类型:
--
作者:
Bhatt,SuryaP;Vegas-Sánchez-Ferrero,Gonzalo;Rahaghi,FarbodN;MacLean,ErickS;Gonzalez-Serrano,German;Come,CarolynE;Kinney,GregoryL;Hokanson,JohnE;Budoff,MatthewJ;Cuttica,MichaelJ;Wells,JMichael;Estépar,RaúlSanJosé;Washko,G
MethodsWe included 3,436 participants with moderate to severe COPD from the multicenter COPDGene cohort (details published previously; ClinicalTrials. gov NCT00608764)(4). Medication data were recorded at enrollment, and we contacted participants prospectively every 3 to 6 months to ascertain exacerbation frequency (2). As previously described, cardiac segmentation and measurement of ventricular volume and sphericity were performed using a statistical model based on nonaffine deformations of cardiac structure to model anatomic variability, with segmentation performed by manual initialization followed by automated, iterative deformation of the model to fit the surface of the heart (3). LV and RV volume were estimated on the basis of the epicardial surface fit and included both the wall and chamber volume. LV and RV sphericity were defined by the ratio of surface area of a sphere the same volume as the cavity divided by the actual surface area of the cavity (3). We also measured the ratio of the diameter of the main pulmonary artery (PA) at the level of its bifurcation to the diameter of the ascending aorta at the same level, using standard DICOM software (OsiriX DICOM Viewer, version 4.0; Bernex, Switzerland)(5).